News & Views
David Ricketts Named CEO at PharmaDiagnostics
Feb 04 2010
PharmaDiagnostics NV, a company developing and marketing label-free screening technology has appointed Dr David Ricketts as Chief Executive Officer and also announces that it has raised EUR 2.5 million in a second round of funding.
Ricketts, 47, DPhil, began his career in Glaxo Group Research, and has held scientific and product sales and marketing positions at British Bio-Technology, Oxford Molecular, and Biosym technologies, becoming VP US Sales and Marketing for Oxford Molecular in 1994. In 1995 he established Oxford Molecular’s Collaborative Discovery division, and was directly involved in the establishment and growth of spin-out companies Cambridge
Combinatorial, Prolysis and Cambridge Drug Discovery. In 2000 he was appointed VP Business Development at Inpharmatica, and 2003 moved to Maybridge as Director, Business Development. Since 2004, he has
acted as aconsultant to companies active in drug discovery and life sciences research and development.
"PharmaDiagnostics’ technology platform is elegant and broadly enabling, and addresses an important market need in the field of label free screening," said Ricketts. "I am looking forward to driving growth of our business and developing new assay products with our excellent existing team, as well as boosting our capabilities with additional senior business and senior scientific staff. The company has great potential and I am committed to
ensuring we realise this potential."
"The addition of David Ricketts as PharmaDiagnostics’ new CEO represents a further step in the growth and professionalism of the company," said Marc Wachsmuth, partner at Capital-E, lead investor in the company’s funding round. "His experience with a wide variety of life science companies means he will provide valuable guidance and management in many aspects of PharmaDiagnostics’ development."
Digital Edition
ILM 49.5 July
July 2024
Chromatography Articles - Understanding PFAS: Analysis and Implications Mass Spectrometry & Spectroscopy Articles - MS detection of Alzheimer’s blood-based biomarkers LIMS - Essent...
View all digital editions
Events
Jul 28 2024 San Diego, CA USA
Jul 30 2024 Jakarta, Indonesia
Jul 31 2024 Chengdu, China
ACS National Meeting - Fall 2024
Aug 18 2024 Denver, CO, USA
Aug 25 2024 Copenhagen, Denmark